Literature DB >> 9735667

Pheochromocytoma complicated with cardiomyopathy after delivery--a case report and literature review.

H J Kim1, D K Kim, S C Lee, S H Yang, J H Yang, W R Lee.   

Abstract

Pheochromocytoma in pregnancy is very rare but it is associated with very high maternal and fetal mortality. Therefore, it is important to include pheochromocytoma in the differential diagnosis of hypertension associated with pregnancy. It is difficult to make a diagnosis of pheochromocytoma in pregnancy before delivery. The characteristic symptoms of pheochromocytoma could be initiated during delivery because the process of delivery, general anesthesia, fetal movement, induce acute surge of catecholamine release, which could also induce cardiomyopathy. Early diagnosis and intensive care can affect the prognosis of cardiomyopathy induced by pheochromocytoma. Proper management with alpha-blockade, beta-blockade and angiotension converting enzyme inhibitor could acutely reverse the course of cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9735667      PMCID: PMC4531952          DOI: 10.3904/kjim.1998.13.2.117

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  16 in total

1.  Reversible dilatation of hypertrophied left ventricle in pheochromocytoma: serial two-dimensional echocardiographic observations.

Authors:  J B Lam; C Shub; S G Sheps
Journal:  Am Heart J       Date:  1985-03       Impact factor: 4.749

2.  Medical management of pheochromocytoma in pregnancy.

Authors:  C W Lyons; G H Colmorgen
Journal:  Obstet Gynecol       Date:  1988-09       Impact factor: 7.661

3.  Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma.

Authors:  J Imperato-McGinley; T Gautier; K Ehlers; M A Zullo; D S Goldstein; E D Vaughan
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

4.  Captopril and phaeochromocytoma.

Authors:  A Israeli; N Gottehrer; D Gavish; R N Melmed
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

5.  Pheochromocytoma-related myocardial damage following delivery.

Authors:  O Satani; M Katsuragi; T Hano; Y Tomobuchi; M Arita; I Nishio
Journal:  Hypertens Res       Date:  1996-12       Impact factor: 3.872

6.  Phaeochromocytoma in pregnancy.

Authors:  P Lau; M Permezel; P Dawson; S Chester; N Collier; I Forbes
Journal:  Aust N Z J Obstet Gynaecol       Date:  1996-11       Impact factor: 2.100

7.  Pheochromocytoma in pregnancy. Experience of treatment with phenoxybenzamine in three patients.

Authors:  G Stenström; K Swolin
Journal:  Acta Obstet Gynecol Scand       Date:  1985       Impact factor: 3.636

Review 8.  Acute reversal of pheochromocytoma-induced catecholamine cardiomyopathy.

Authors:  A S Nanda; A Feldman; C S Liang
Journal:  Clin Cardiol       Date:  1995-07       Impact factor: 2.882

Review 9.  Pheochromocytoma-induced myocardial infarction in pregnancy. A case report and literature review.

Authors:  C R Jessurun; K Adam; K J Moise; S Wilansky
Journal:  Tex Heart Inst J       Date:  1993

10.  Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure.

Authors:  S H Sardesai; A J Mourant; Y Sivathandon; R Farrow; D O Gibbons
Journal:  Br Heart J       Date:  1990-04
View more
  2 in total

Review 1.  Diagnosis and management of pheochromocytoma during pregnancy.

Authors:  M Mannelli; D Bemporad
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

2.  Implications and considerations during pheochromocytoma resection: A challenge to the anesthesiologist.

Authors:  Sukhminderjit Singh Bajwa; Sukhwinder Kaur Bajwa
Journal:  Indian J Endocrinol Metab       Date:  2011-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.